Figure 5From: Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands Sensitivity analyses on the price differential of the bivalent and quadrivalent HPV-vaccines. A positive price difference indicates that the quadrivalent vaccine can be more expensive to be as cost-effective as the bivalent vaccine.Back to article page